Novel glycolipid mimetics able to express anti-inflammatory or adjuvant activity in a context dependent manner. The compounds can be used for the treatment of immune diseases cursed with Th1/Th2 imbalance or as vaccine adjuvants.
Obtained from the best barleys of six races developed in the national public improvement program, widely cultivated in Spain (Cierzo, Yuriko, Estrella), with the additional contribution of a local Spanish variety of good performance, identified in the CSIC.
Combination of enzymes that carries out the conversion of secoisolariciresinol diglucoside (SDG) to matairesinol with high yield. It enables the production of food compositions of great interest since matairesinol exhibits health-beneficial activities.